| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey.
Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey.
Maher L, Wand H, Heard S, Starr M, Zolala F, Kemp R, Cunningham P, Drummer H, Hellard M, Kaldor J, Dore G.
Int J Drug Policy. 2024 Sep 30:104576. doi: 10.1016/j.drugpo.2024.104576. Epub ahead of print. PMID: 39353802.
https://www.sciencedirect.com/science/article/pii/S0955395924002603